BioSpace News Archive

Biotech Bay

Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT™

Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.

August 15, 2022
·
2 min read
Business

Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update

Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug-development company focused on DNA-mediated immunotherapy and next-generation vaccines, today announced financial results for the three and six months ended June 30, 2022.

August 15, 2022
·
18 min read
Business

Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today reported financial results for the quarter ended June 30, 2022 and provided a corporate update.

August 15, 2022
·
8 min read
Business

AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), today reported its financial results for the second quarter 2022 and provided a business update.

August 15, 2022
·
12 min read
BioMidwest

Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing

Regenative Labs, a leading HCT/P manufacturer, has co-authored a pioneering paper together with experts from The Institute of Regenative Medicine and the Department of Pharmacology and Chemical Biology, Baylor College of Medicine.

August 15, 2022
·
3 min read
Genetown

Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus

Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical trial designed to determine the baseline characteristics of patients diagnosed with recurrent symptomatic herpes simplex virus type 2 (HSV-2).

August 15, 2022
·
3 min read
Business

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Q32 Bio and Horizon Therapeutics plc, announced that they have entered into a collaboration and option agreement to develop ADX-914 for the treatment of autoimmune diseases.

August 15, 2022
·
5 min read
BioCapital

Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older

Novavax, Inc. today announced that it submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its protein-based COVID-19 Vaccine, Adjuvanted.

August 15, 2022
·
13 min read
Business

Curate Biosciences Appoints Daniel Getts, Ph.D. to its Board of Directors

Curate Biosciences today announced that Daniel Getts, Ph.D., cofounder and CEO of Myeloid Therapeutics, has been appointed to its Board of Directors.

August 15, 2022
·
3 min read
Business

CNS Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

CNS PHARMACEUTICALS AG Inc. today reported its financial results for the quarter ended June 30, 2022 and provided a clinical update of its anti-cancer drug candidates currently in development for the treatment of primary and metastatic brain and CNS cancer.

August 15, 2022
·
9 min read